Target intelligence / Profile preview

Cytochrome b-245 heavy chain (NOX2) (NOX2)

Target
NOX2
Molecular classification
Enzyme, Oxidoreductase, NADPH oxidase (NOX) family, Flavoprotein (UniProt P04839)
01

Overview

Cytochrome b-245 heavy chain, commonly referred to as gp91-phox or NOX2, is the primary catalytic subunit of the phagocyte NADPH oxidase complex (UniProt P04839). It is a transmembrane protein that facilitates the transfer of electrons from NADPH to molecular oxygen, resulting in the production of superoxide anions (NCBI Gene: 1536). This respiratory burst is a critical component of the innate immune system, enabling phagocytes such as neutrophils and macrophages to destroy invading pathogens (StatPearls: Chronic Granulomatous Disease). While essential for host defense, dysregulated or excessive NOX2 activity is a major source of oxidative stress, contributing to the pathogenesis of inflammatory diseases, neurodegeneration, and cardiovascular disorders (Bedard & Krause, 2007). Mutations in the CYBB gene, which encodes this protein, result in X-linked Chronic Granulomatous Disease (CGD), a condition marked by life-threatening infections and granuloma formation (StatPearls). Consequently, NOX2 is a high-priority target for the development of antioxidants and anti-inflammatory therapies aimed at modulating reactive oxygen species production. Pharmacological inhibition of NOX2 is being explored to treat conditions like stroke and myocardial infarction where oxidative damage is prevalent. However, therapeutic strategies must balance the reduction of harmful ROS with the preservation of essential immune functions.

Other names
gp91-phoxCYBBCytochrome b(558) subunit betaNADPH oxidase 2CGD91-phoxHeme-binding membrane glycoprotein gp91phox
02

Mechanism of action

Inhibition of the catalytic activity of the NOX2 complex to prevent the generation of superoxide anions from molecular oxygen (UniProt P04839).

03

Biological functions

Superoxide anion generation (UniProt P04839)Respiratory burst (StatPearls)Innate immune response (UniProt P04839)Phagocytosis-mediated pathogen killing (NCBI Gene: 1536)Redox signaling (Bedard & Krause, 2007)
04

Disease associations

Chronic Granulomatous Disease (StatPearls)Inflammation (Bedard & Krause, 2007)Neurodegenerative disease (Alzheimer's, Parkinson's) (NCBI Gene: 1536)Cardiovascular disease (Atherosclerosis, Hypertension) (Bedard & Krause, 2007)Ischemia-reperfusion injury (Stroke, Myocardial infarction)
05

Safety considerations

Increased risk of infection by catalase-positive organisms (e.g., Staphylococcus aureus, Aspergillus) (StatPearls)Impaired wound healingPotential for inducing a Chronic Granulomatous Disease-like phenotypeImpaired inflammatory resolution
06

Interacting drugs

GSK2795039

3 more in the full profile.

07

Biomarkers

Dihydrorhodamine 123 (DHR) flow cytometry for superoxide production (StatPearls)Nitroblue tetrazolium (NBT) reduction test (StatPearls)CYBB gene sequencing for Chronic Granulomatous Disease diagnosis (NCBI Gene: 1536)Plasma levels of reactive oxygen species (ROS) metabolites

Beyond the preview

Go deeper on Cytochrome b-245 heavy chain (NOX2) (NOX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b-245 heavy chain (NOX2) (NOX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call